Clinical Trials · NCT02195635

Phase 1, Open-label, Drug-drug Interaction Study With Octreotide Acetate Injection and Telotristat Etiprate in Healthy Subjects

Name: Phase 1, Open-label, Drug-drug Interaction Study With Octreotide Acetate Injection and Telotristat Etiprate in Healthy Subjects
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 1Octreotide

Phase: Phase 1
Recruitment status: Completed
Sponsor: Lexicon Pharmaceuticals
Enrollment: 24
Start date: Jul 2014
Locations: 1 site, United States
Primary endpoint: Plasma concentrations of telotristat ethyl

View Octreotide compound reference